DMRA · Damora Therapeutics, Inc. · Congressional Trades
$28.10
+1.26 (+4.69%)
At close · Sep 11
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.73B
Shares
61.74M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
52 filings
52 filers
Visit website
Investor relations